Stock Value
Competitors
| Ticker | Price | Forecast 1Y | Forecast 2Y | Market Cap | Div Yld | Growth Rate |
|---|---|---|---|---|---|---|
|
NYSE:PFE
Pfizer
|
28.64 | 8.42% | 38.65% | 162,291.22 | 5.81% | -9.31% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61.74% | 72.08% | 89,253.22 | 5.44% | 13.54% |
|
NasdaqGS:IDXX
IDEXX Laboratories
|
543.45 | -1.93% | 11.41% | 44,882.08 | 0% | 18.75% |
|
NYSE:IQV
IQVIA Holdings
|
231.18 | 17.25% | 34.12% | 42,121 | 0% | 12.94% |
|
NasdaqGS:ICLR
ICON Public
|
314.72 | 8.72% | 23.9% | 26,022.25 | 0% | 16% |
|
NYSE:LH
Laboratory Corp of America Holdings
|
210.59 | -11.18% | -1.66% | 17,751.4 | 1.35% | 4.24% |
|
SWX:SGSN
SGS
|
80.72 | 887.92% | 968.45% | 15,278.36 | 3.95% | -1.74% |
|
NYSE:DGX
Quest Diagnostics
|
144.34 | -10.75% | -2.08% | 16,034.96 | 2.11% | 6.66% |
|
ENXTPA:BVI
Bureau Veritas
|
27.52 | 4.59% | 15.11% | 12,884.95 | 3.01% | 5.76% |
|
ENXTPA:ERF
Eurofins Scientific
|
58.26 | 14% | 29.25% | 11,046.73 | 0.84% | 7.46% |
|
NYSE:CRL
Charles River Laboratories International
|
221.61 | 15.62% | 31.45% | 11,815.07 | 0% | 12.09% |
|
NasdaqGS:NTRA
Natera
|
106.46 | 0% | 0% | 11,680.18 | 0% | 0% |
|
LSE:ITRK
Intertek Group
|
49.54 | 5,998.22% | 6,510.77% | 8,150.85 | 2.26% | 2.41% |
|
NasdaqCM:EXAS
Exact Sciences
|
50.38 | 0% | 0% | 9,955.48 | 0% | 0% |
|
ASX:RHC
Ramsay Health Care
|
49.99 | -5.73% | 39.17% | 11,735.1 | 1.28% | -12.58% |
|
NasdaqGM:SYNH
Syneos Health
|
42.98 | 39.17% | 62.46% | 2,638.18 | 0% | 15.77% |
|
OM:MCOV B
Medicover AB (publ)
|
195.20 | 9.85% | 76.31% | 26,189.17 | 0.71% | -3.2% |
|
NasdaqGS:GH
Guardant Health
|
25.36 | 0% | 0% | 2,369.45 | 0% | 0% |
|
NasdaqCM:NEO
NeoGenomics
|
14.80 | -,131.68% | -58.73% | 1,953.99 | 0% | 0% |
|
XTRA:EVT
Evotec
|
9.76 | -32.05% | 101.29% | 1,726.81 | 0% | 0% |
